An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells.
Open Access
- 1 April 1985
- journal article
- research article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 100 (4), 1041-1049
- https://doi.org/10.1083/jcb.100.4.1041
Abstract
Heparan sulfate was isolated form the cell surface, cell pellet, and culture medium of exponentially growing as well as postconfluent bovine aortic smooth muscle cells (SMCs). After chromatography on DEAE-Sephadex and Sepharose 4B, the various mucopolysaccharides were examined for their ability to cause growth inhibition in a SMC bioassay. The heparan sulfate isolated from the surface of postconfluent SMCs possessed approximately eight times the antiproliferative potency per cell of the heparan sulfate obtained from the surface of exponentially growing SMCs. Heparan sulfate isolated from other fractions of exponentially growing or postconfluent SMCs possesses little growth inhibitory activity. The difference in the antiproliferative activities of heparan sulfate obtained from the surface of SMCs in the two growth states could not be attributed to the synthesis of a greater mass of mucopolysaccharide by postconfluent SMCs. Indeed, heparan sulfate isolated from the surface of the postconfluent SMCs exhibits a specific antiproliferative activity which is 13-fold greater than mucopolysaccharide obtained from the surface of exponentially growing SMCs and more than 40-fold greater than commercially available heparin. In addition, exponentially growing SMCs did not exhibit an enhanced ability to degrade the complex carbohydrate. Furthermore, other investigations indicate that the small amount of growth inhibitory activity intrinsic to heparan sulfate isolated from the surface of exponentially growing SMCs is due to residual, biologically active, mucopolysaccharide produced by the primary postconfluent SMCs from which the exponentially growing SMCs were derived. These studies suggest that bovine aortic SMCs are capable of controlling their own growth by the synthesis of a specific form of heparan sulfate with antiproliferative potency.This publication has 29 references indexed in Scilit:
- Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cellsJournal of Cellular Physiology, 1984
- Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.JCI Insight, 1984
- Biochemical properties of the endothelium‐derived growth factor: Comparision to other growth factorsJournal of Cellular Physiology, 1983
- Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growthThe Journal of cell biology, 1981
- Glycosaminoglycan synthesis and composition in human fibroblasts during in vitro cellular aging (IMR-90)Journal of Cellular Physiology, 1981
- Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin.Circulation Research, 1980
- Fibronectin and proteoglycans as determinants of cell‐substratum adhesionJournal of Supramolecular Structure, 1979
- Suppression by heparin of smooth muscle cell proliferation in injured arteriesNature, 1977
- Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate.The Journal of cell biology, 1976
- Atherosclerosis and the Arterial Smooth Muscle CellScience, 1973